Johnson & Johnson Targets FDA Approval for Groundbreaking gMG Drug Amidst Fierce Competition
Aug 30, 2024
Drug Invest Information
Intelligent Bio Solutions Inc. Addresses the Escalating Demand for Workplace Drug Testing Solutions
Aug 14, 2024
Immix Biopharma Receives EU Orphan Drug Designation for NXC-201 in Multiple Myeloma
Apr 29, 2024
SpringWorks Therapeutics Begins Rolling NDA Submission for NF1-PN Treatment
Mar 5, 2024
MindMed's Strategic Shift in 2024: Focusing on Anxiety Treatments and Halting LSD Microdosing for ADHD
Jan 11, 2024
AstraZeneca AZN Cancels Two Key Phase III Trials for Hyperkalemia Drug Lokelma
Dec 2, 2023
SciSparc Ltd. Embarks on Transformative Phase IIb Trial for Tourette Syndrome Using THC-Based Medication
Nov 11, 2023
Pasithea Therapeutics Advances ALS Treatment with New Lead Candidate PAS-003 Targeting α5β1 Integrin
Nov 9, 2023